Real-world Effectiveness of Adalimumab on Health Outcomes in Chinese Patients With Immune-Mediated Inflammatory Diseases

Clinical trial NCT03339089 · COMPLETED

Trial details

NCT number: NCT03339089
Sponsor: AbbVie
Status: COMPLETED
Study type: OBSERVATIONAL

Ankylosing Spondylitis (AS)Psoriasis Rheumatoid Arthritis (RA)

Start date: 2018-05-18
Primary completion: 2021-07-08
Enrollment: 224

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.